Abstract
Three types of specific Ap4.A-degrading enzymes are known: asymmetrical Ap4 A hydrolase, asymmetrical Ap4.A hydrolase and Ap4. A α,β-phosphorylase (ADP-forming). Since each of the enzymes is specific for different kingdom of the organisms and differs both in the mode of Ap.A degradation, interaction with metal ions and in substrate specificity, one can anticipate that new family of drugs could be designed which would selectively inhibit the microbial (bacterial, fungal or protozoan) enzymes without affecting the mammalian or plant counterparts.